Semaglutide and Hair Loss: What to Track Before You Change Your Plan

What is known and unknown about semaglutide and hair shedding

Current evidence includes observational signals and trial safety reporting, but hair outcomes are not always measured as a primary endpoint in obesity trials.

That means concern is valid, but causality can be hard to prove at the individual level without tracking context, timing, and concurrent stressors.

A practical approach is to collect high-quality symptom data before changing therapy.

Sources: [1] [2] [4] [7]

Hair-loss tracking checklist (table-style)

Bring this log to your appointment so the next decision is evidence-informed rather than reaction-driven.

• Timeline column: date of first shedding change, dose adjustments, major stressors, illness episodes, and menstrual/hormonal changes.
• Pattern column: diffuse shedding vs patchy loss, scalp symptoms, and whether breakage vs root shedding is observed.
• Nutrition column: daily protein consistency, major calorie restriction, and potential iron/zinc/protein intake concerns to discuss with care team.
• Medication column: all active medications/supplements and any recent starts/stops.
• Action column: when symptoms improve, persist, or worsen after each plan adjustment.

Sources: [1] [2] [3] [5] [6]

Questions to ask before changing your semaglutide plan

• Could this be telogen effluvium related to rapid weight loss or another trigger?
• Are there labs or nutrition assessments we should review before dose changes?
• What warning signs mean urgent dermatology or primary-care follow-up?
• If we adjust treatment, what outcome and timeline would indicate improvement?

Sources: [1] [2] [3] [4]

Bottom line

If you notice hair shedding while using semaglutide, document the pattern first and review it with your clinician before making abrupt changes.

A timeline-based approach improves signal quality and supports safer, more individualized decisions.

Sources: [2] [3] [6]